Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 551

The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.

SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology

Open access
Ogando, Natacha S., Dalebout, Tim J., Zevenhoven-Dobbe, Jessika C., Limpens, Ronald W.A.L., van der Meer, Yvonne, Caly, Leon, Druce, Julian, de Vries, Jutte J. C., Kikkert, Marjolein, Bárcena, Montserrat, Sidorov, Igor, Snijder, Eric J. · 2020 · Journal of General Virology

Published version of a preprint

Abstract

The sudden emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the end of 2019 from the Chinese province of Hubei and its subsequent pandemic spread highlight the importance of understanding the full molecular details of coronavirus infection and pathogenesis. Here, we compared a variety of replication features of SARS-CoV-2 and SARS-CoV and analysed the cytopathology caused by the two closely related viruses in the commonly used Vero E6 cell line. Compared to SARS-CoV, SARS-CoV-2 generated higher levels of intracellular viral RNA, but strikingly about 50-fold less infectious viral progeny was recovered from the culture medium. Immunofluorescence microscopy of SARS-CoV-2-infected cells established extensive cross-reactivity of antisera previously raised against a variety of non-structural proteins, membrane and nucleocapsid protein of SARS-CoV. Electron microscopy revealed that the ultrastructural changes induced by the two SARS viruses are very similar and occur within comparable time frames after infection. Furthermore, we determined that the sensitivity of the two viruses to three established inhibitors of coronavirus replication (remdesivir, alisporivir and chloroquine) is very similar, but that SARS-CoV-2 infection was substantially more sensitive to pre-treatment of cells with pegylated interferon alpha. An important difference between the two viruses is the fact that – upon passaging in Vero E6 cells – SARS-CoV-2 apparently is under strong selection pressure to acquire adaptive mutations in its spike protein gene. These mutations change or delete a putative furin-like cleavage site in the region connecting the S1 and S2 domains and result in a very prominent phenotypic change in plaque assays.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1099/jgv.0.001453

Cites

104 of 104 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 13

  1. 10.1038/s41586-020-2008-3 · DOI · Paper page
  2. 10.1128/JVI.68.9.5755-5764.1994 · doi:10.1128/jvi.68.9.5755-5764.1994
  3. 10.1007/978-0-387-33012-9_27 · doi:10.1007/978-0-387-33012-9_27
  4. 10.1128/AAC.00939-08 · doi:10.1128/aac.00939-08
  5. Riss, 2004, Assay Guidance Manual
  6. 10.1038/s41586-020-2012-7 · DOI · Paper page
  7. 10.1016/j.cell.2020.02.058 · doi:10.1016/j.cell.2020.02.058 · Paper page
  8. Liu, 2020, Identification of a common deletion in the spike protein of SARS-CoV-2, bioRxiv
  9. 10.1101/2020.03.27.012906 · doi:10.1101/2020.03.27.012906
  10. Lokugamage, 2020, SARS-CoV-2 sensitive to type I interferon pretreatment, bioRxiv
  11. 10.1128/IAI.8.3.309-316.1973 · doi:10.1128/iai.8.3.309-316.1973
  12. 10.1007/978-1-4615-1899-0_79 · doi:10.1007/978-1-4615-1899-0_79
  13. 10.1016/S1672-0229(03)01028-3 · doi:10.1016/s1672-0229(03)01028-3

Cited by

See all 551

Metadata

Authors
Ogando, N. S., Dalebout, T. J., Zevenhoven-Dobbe, J. C., Limpens, R. W. A. L., van der Meer, Y., Caly, L., Druce, J., de Vries, J. J. C., Kikkert, M., Bárcena, M., Sidorov, I., & Snijder, E. J.
Venue
Journal of General Virology
Published
2020-09-01
Volume
101
Issue
9
Pages
925-940
ISSN
  • 0022-1317 (ISSN-L)
  • 1465-2099
OpenAlex
W3036391214
Cited by
551
References
104
FWCI
12.80
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.